Eyal Rubin

Eyal Rubin

No open positions remaining
49 year
Health Technology
Consumer Services
Commercial Services

Profile

Eyal Rubin is Chief Financial Officer & Executive Vice President at Nasus Pharma Ltd. since 2025.
Former roles include CFO, Secretary, Treasurer & Senior Vice President at Protalix Biotherapeutics, Inc. from 2019 to 2025; Chief Financial Officer, Treasurer & Executive VP at Brainstorm Cell Therapeutics, Inc. from 2017 to 2019; Vice President & Head-Treasury at Teva Pharmaceutical Industries Ltd. from 2013 to 2017; Head-Finance & Banking Department at Cellcom Israel Ltd. from 2010 to 2013; Chief Financial Officer at Idt Carmel, Inc. from 2006 to 2010; Chief Financial Officer & General Manager at V-Secure Technologies, Inc. from 2003 to 2005; Chief Operating Officer & Vice President-Finance at Sec2Wireless, Inc. from 1999 to 2003.
Education includes an MBA from Bar-Ilan University and an undergraduate degree from The College of Management Academic Studies.

Former positions of Eyal Rubin

CompaniesPositionEnd
NASUS PHARMA LTD. Director of Finance/CFO 17/09/2026
PROTALIX BIOTHERAPEUTICS, INC. Director of Finance/CFO 23/08/2025
BRAINSTORM CELL THERAPEUTICS INC. Director of Finance/CFO 05/09/2019
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 31/12/2016
CELLCOM ISRAEL LTD. Corporate Officer/Principal 28/02/2013
See the detail of Eyal Rubin's experience

Training of Eyal Rubin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Commercial Services

Communications

Consumer Services

Electronic Technology

Health Technology

Consumer Services

Idt Carmel, Inc.

Health Technology